Carlos Guevara Oliva
Profesor Asistente
Hospital Clínico de la Universidad de Chile
Santiago, Chile
Clinical neurosciences in particular neurodegenerative diseases and quantitative neuroimaging
-
PhD in clinical neurosciences, KINGS COLLEGE LONDON. Reino Unido, 2011
-
Medico Cirujano, UNIVERSIDAD DE CONCEPCION. Chile, 1998
-
Neurologo, UNIVERSIDAD DE CHILE. Chile, 2001
-
Profesor Assitente Full Time
UNIVERSIDAD DE CHILE
Hospital Clínico
Santiago, Chile
2011 - At present
-
Researcher Part Time
King´s College London
Londres, Reino Unido
2007 - 2011
DOES CORTICAL ATROPHY TAKE PLACE AFTER BASAL GANGLIA DAMAGE IN MULTIPLE SYSTEM ATROPHY AND PROGRESSIVE SUPRANUCLEAR PALSY? |
Ocular myasthenia and dysautonomia associated to thymoma [Miastenia ocular y disautonomía asociadas a timoma] |
Interferon-gamma-induced regulatory T cell response is dependent on PD-1/PD-L1 pathway in experimental autoimmune encephalomyelitis and multiple sclerosis (2019-2023) |
Methods for tractography-based parcellation of the cortical surface (2019-2022) |
XIII Concurso Proyectos Investigación y Desarrollo en Atrofia cerebral global como criterio nuevo para escalar desde terapia de primera línea a segunda línea en esclerosis múltiple recurrente-remitente |
VOXEL BASED MORPHOMETRY IN IDIOPATHIC PARKINSON DISEASE AND PARKINSON PLUS SYNDROMES=>REFLECTING THE ONGOING NEURONAL LOSS |
“A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis”. Mitotarget study group. European Journal of Neurology 2014, 21=> 529–536. |
“Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS)” |
Neuroproteccion and Natural History of Parkinson Plus Syndromes, Phase 3 Study of Riluzole in Multiple System Atrophy and Progressive Supranuclear Palsy |